Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

ClinicalTrials.gov ID: NCT02367313

Public ClinicalTrials.gov record NCT02367313. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 7:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection

Study identification

NCT ID
NCT02367313
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Biota Pharmaceuticals, Inc.
Industry
Enrollment
455 participants

Conditions and interventions

Conditions

Interventions

  • Vapendavir Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2015
Primary completion
Nov 30, 2016
Completion
Nov 30, 2016
Last update posted
May 31, 2018

2015 – 2016

United States locations

U.S. sites
33
U.S. states
22
U.S. cities
33
Facility City State ZIP Site status
Biota Investigational site Birmingham Alabama 35209
Biota Investigational site Flagstaff Arizona 86001
Biota Investigational site Bakersfield California 93301
Biota Investigational site Los Angeles California 90025
Biota Investigational site Orange California 92868
Biota Investigational Site San Jose California 95117
Biota Investigational site Stockton California 95207
Biota Investigational site Centennial Colorado 80112
Biota Investigational site Denver Colorado 80230
Biota Investigational site Hialeah Florida 33016
Biota Investigational site New Port Richey Florida 34653
Biota Investigational site Oviedo Florida 32765
Biota Investigation site Palmetto Bay Florida 33157
Biota Investigational site Tallahassee Florida 32308
Biota Investigational site Twin Falls Idaho 83301
Biota Investigational site Baltimore Maryland 21236
Biota Investigational site St Louis Missouri 63141
Biota Investigational site Bellevue Nebraska 68123
Biota investigational site Las Vegas Nevada 89146
Biota Investigational site Ocean City New Jersey 07712
Biota Investigational site Albuquerque New Mexico 87102
Biota Investigational site Rockville Centre New York 11570
Biota Investigational site Raleigh North Carolina 27607
Biota Investigational site Fargo North Dakota 58103
Biota Investigational site Middleburg Ohio 44310
Biota Investigational site Toledo Ohio 43617
Biota Investigation site Oklahoma City Oklahoma 73120
Biota Investigational site Medford Oregon 97504
Biota Investigational site Portland Oregon 97202
Biota Investigational site Warwick Rhode Island 02886
Biota Investigational site Houston Texas 77055
Biota Investigational site Seattle Washington 98115
Biota Investigational site Greenfield Wisconsin 53228

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02367313, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 31, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02367313 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →